Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Medication Errors Topic Center

Featured Article

News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
Commentary
A Small Apology Can Go a Long Way in Pharmacy
04/03/2023
"It’s time for health care practitioners to reevaluate their response to potential errors and approach it as a learning opportunity that will help increase patient safety," says Sadik Owolewa, PharmD.
"It’s time for health care practitioners to reevaluate their response to potential errors and approach it as a learning opportunity that will help increase patient safety," says Sadik Owolewa, PharmD.
"It’s time for health care...
04/03/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Blood Thinner Recalled
03/02/2023
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Sanitizing Products Recalled
02/10/2023
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Beta-Blocker Recalled
02/02/2023
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is...
02/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network

Newsfeed

News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Blood Thinner Recalled
03/02/2023
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
News
Sanitizing Products Recalled
02/10/2023
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network
News
Beta-Blocker Recalled
02/02/2023
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is...
02/02/2023
Pharmacy Learning Network
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Insights

Commentary
A Small Apology Can Go a Long Way in Pharmacy
04/03/2023
"It’s time for health care practitioners to reevaluate their response to potential errors and approach it as a learning opportunity that will help increase patient safety," says Sadik Owolewa, PharmD.
"It’s time for health care practitioners to reevaluate their response to potential errors and approach it as a learning opportunity that will help increase patient safety," says Sadik Owolewa, PharmD.
"It’s time for health care...
04/03/2023
Pharmacy Learning Network
Commentary
Pharmacy Management/Distribution and Communication Errors Associated With Use of Oxytocin and Strategies to Mitigate Risk of Such Errors: Part III
05/21/2020
In part III of this series, Neha Kumar, PharmD, discusses errors associated with pharmacy management and distribution of oxytocin, as well as other communication errors, and also provides mitigation strategies.
In part III of this series, Neha Kumar, PharmD, discusses errors associated with pharmacy management and distribution of oxytocin, as well as other communication errors, and also provides mitigation strategies.
In part III of this series, Neha...
05/21/2020
Pharmacy Learning Network
Commentary
Administration Errors Associated With Use of Oxytocin and Strategies to Mitigate Risk of Such Errors: Part II
05/12/2020
In part II, Neha Kumar, PharmD, 2019-2020 FDA/ISMP Safe Medication Management Fellow, discusses a variety of errors that were associated with administration of oxytocin as well as risk mitigation strategies.
In part II, Neha Kumar, PharmD, 2019-2020 FDA/ISMP Safe Medication Management Fellow, discusses a variety of errors that were associated with administration of oxytocin as well as risk mitigation strategies.
In part II, Neha Kumar,...
05/12/2020
Pharmacy Learning Network
Examining Pharmacy Dispensing, Medication Safety Amid COVID-19
Videos
Examining Pharmacy Dispensing, Medication Safety Amid COVID-19
04/09/2020
Matthew Grissinger, RPh, director of error reporting, ISMP, discusses cross-contamination risk of COVID-19 when handling medications and provides tips to help mitigate this risk.
Matthew Grissinger, RPh, director of error reporting, ISMP, discusses cross-contamination risk of COVID-19 when handling medications and provides tips to help mitigate this risk.
Matthew Grissinger, RPh,...
04/09/2020
Pharmacy Learning Network
Commentary
Prescribing Errors Associated With Use of Oxytocin and Strategies to Mitigate Risk of Such Errors: Part I
04/09/2020
Neha Kumar, PharmD, discusses how improper administration of oxytocin can impact patients, and provides tips that support the correct selection and appropriate use of medications.
Neha Kumar, PharmD, discusses how improper administration of oxytocin can impact patients, and provides tips that support the correct selection and appropriate use of medications.
Neha Kumar, PharmD, discusses...
04/09/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Recent Stories

News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement